Health care stocks were advancing pre-bell Monday, with the Health Care Select Sector SPDR Fund (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) 0.8% higher.

Summit Therapeutics (SMMT) stock was down more than 8% after the company posted a wider Q3 non-GAAP net loss.

CorMedix (CRMD) shares were up 13% after the company reported Q3 preliminary net revenue Monday of $100 million and raised its 2025 pro forma net revenue outlook.

Glaukos (GKOS) shares were up more than 3% after the company said its new drug application for Epioxa, a topical drug therapy for the eye disorder keratoconus, has been approved by the US Food and Drug Administration.